Vanguard shows 5.5% Legence (LGN) stake in 13G filing
Rhea-AI Filing Summary
The Vanguard Group has filed a Schedule 13G reporting beneficial ownership of Legence Corp common stock. Vanguard reports beneficial ownership of 3,227,670 shares, representing 5.5% of the class as of the triggering event on 12/31/2025.
Vanguard reports shared voting power over 249,483 shares and shared dispositive power over 3,227,670 shares, with no sole voting or dispositive power. The position is held in the ordinary course of business and is not intended to change or influence control of Legence.
The filing notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries or business divisions are expected to report beneficial ownership separately while pursuing the same investment strategies as before. Vanguard states its clients have rights to dividends and sale proceeds, with no single client holding more than 5% of the class.
Positive
- None.
Negative
- None.
Insights
Vanguard reports a 5.5% passive institutional stake in Legence.
The Vanguard Group discloses beneficial ownership of 3,227,670 Legence common shares, or 5.5% of the class, under a Schedule 13G. The 13G format and certification emphasize that the position is held in the ordinary course of business, without a control-seeking purpose.
The filing shows shared voting power over 249,483 shares and shared dispositive power over 3,227,670 shares, with no sole authority. This indicates a broadly held, client-driven position typical of a large asset manager rather than a concentrated activist stake.
The internal realignment on January 12, 2026 means certain Vanguard subsidiaries or business divisions may later report ownership separately on a disaggregated basis, while continuing the same investment strategies. Future ownership reports may therefore appear under multiple related entities rather than solely under The Vanguard Group, Inc.